The city of Kansas City, Missouri, currently has 1 active clinical trials seeking participants for Pulmonary Fibrosis research studies.
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Recruiting
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
Gender:
All
Ages:
40 years and above
Trial Updated:
03/01/2024
Locations: Saint Luke's Hospital of Kansas City, Kansas City, Missouri
Conditions: Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease